<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The 6;9 chromosomal translocation [t(6;9)] is usually associated with <z:hpo ids='HP_0011009'>acute</z:hpo> nonlymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo>, and carries a poor prognosis </plain></SENT>
<SENT sid="1" pm="."><plain>We present a case of <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e>) accompanied by t(6;9) </plain></SENT>
<SENT sid="2" pm="."><plain>Review of the literature revealed an additional ten patients in which <z:hpo ids='HP_0002863'>myelodysplastic syndrome</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>) was associated with the chromosomal translocation 6;9 </plain></SENT>
<SENT sid="3" pm="."><plain>The patients tend to be younger then the average <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> patient and, unlike <z:hpo ids='HP_0001909'>leukemia</z:hpo>, in which this translocation is associated with a poor prognosis, these patients tend to have the same overall <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">RAEB</z:e> and <z:hpo ids='HP_0005505'>refractory anemia</z:hpo> with excess of blasts in transformation (RAEBt) prognosis </plain></SENT>
<SENT sid="4" pm="."><plain>It is therefore possible that this chromosomal aberration should not be considered as an unfavorable prognostic factor in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> </plain></SENT>
</text></document>